Upexi, Inc. (UPXI) insider trading.
In Q3 2026, insiders at Upexi, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-07-20
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Norstrud Andrew James | Director, Officer · Chief Financial Officer | 1 | 0 | 0 |
| Marshall Allan | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
| Rudick Brian Benjamin | Officer · Chief Strategy Officer | 1 | 0 | 0 |
| Dugan Lawrence | Director | 1 | 0 | 0 |
| Salkind Gene | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-03 | Norstrud Andrew James | A (A) | 400,000 | $0 | 1,049,138 | Form 4 |
| 2026-07-03 | Marshall Allan | A (A) | 2,000,000 | $0 | 6,046,261 | Form 4 |
| 2026-07-03 | Rudick Brian Benjamin | A (A) | 400,000 | $0 | 1,238,597 | Form 4 |
| 2026-07-03 | Dugan Lawrence | A (A) | 100,000 | $0 | 216,389 | Form 4 |
| 2026-07-03 | Salkind Gene | A (A) | 100,000 | $0 | 318,750 | Form 4 |
Transaction codes in this quarter
Get UPXI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1775194&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · UPXI company page · Upexi, Inc. on SEC.gov
Questions
Are insiders buying or selling Upexi, Inc. (UPXI)?
In Q3 2026, insiders at Upexi, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Upexi, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/upxi.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.